Department of Medicine
-
January 20, 2023
Vanderbilt mourns loss of ASAP co-founder Murray
John Joseph Murray V, MD, PhD, a co-founder of the Vanderbilt University Medical Center Asthma, Sinus and Allergy Program (ASAP), died on Jan. 6 at Vanderbilt University Hospital. -
January 19, 2023
Study points to new ways to prevent, treat heart disease
Vanderbilt researchers have confirmed the existence of an alternative pathway to atherosclerosis, a finding that may lead to new ways to prevent and treat cardiovascular disease. -
January 19, 2023
Is drinking tea good for your gut?
Microbiome profiling of older Chinese adults showed that tea drinking changed the diversity and abundance of some bacteria in men but not women — effects that may contribute to a reduced risk of hypertension. -
January 19, 2023
Emerging Infections Program lands national award for COVID response
Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry. -
January 19, 2023
Low potassium injures kidney
Vanderbilt researchers have discovered that low dietary potassium causes direct kidney injury, suggesting potential new targets for treating chronic kidney disease. -
January 13, 2023
Study identifies potential new approach for treating lupus
A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus. -
January 12, 2023
Chan Zuckerberg Initiative grant supports single-cell study of rare inherited disease
A multidisciplinary team led by Vanderbilt University Medical Center investigator Alexander Bick, MD, PhD, has been awarded a $2 million, four-year grant to study inflammation at the single-cell level in the rare disease RUNX1-FPD.